Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $57 |
| Triangulated Fair Value | $47 |
| 12-mo Scenario PWEV | $58 |
| Implied Return | -19% |
| Forward P/E | 12.8x |
| Market Cap | $20B |
| 52-Week Range | $49 – $69 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Spike — Supply Dislocation' (8% weight) — targets $118, +105% vs spot. It needs Gross Margin to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($57) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Crush / Protein Margin Reset' (22%) — targets $20, -64% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Gross Margin explains 68% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.55 vs analyst floor +0.07 → delta +0.47 (n=20 mgmt / 12 Q&A; 67th pctile across the S&P book, z +0.5).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.55 | +0.07 | +0.47 |
| 2026Q1 | +0.50 | +0.17 | +0.33 |
| 2025Q4 | +0.47 | +0.13 | +0.34 |
| 2025Q3 | +0.54 | +0.40 | +0.14 |
News (last 365d, 966 articles): avg ticker sentiment +0.13 (bullish 7% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — Crush / Protein Margin Reset' downside ($20) to a 'Spike — Supply Dislocation' bull case ($118); the probability-weighted blend (PWEV $58) is +2% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Crush / Protein Margin Reset | 22% | $20 | -64% |
| Cyclical Margin Trough | 18% | $36 | -37% |
| Base — Mid-Cycle Crush / Protein Margins | 32% | $59 | +3% |
| Upcycle — Tight Margins | 20% | $94 | +64% |
| Spike — Supply Dislocation | 8% | $118 | +105% |
| Probability-Weighted (PWEV) | — | $58 | +2% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Crush / Protein Margin Reset (22%, $20). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 20.4; probability: 0.22.
- Cyclical Margin Trough (18%, $36). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising. Drivers — implied_target: 36.32; probability: 0.18.
- Base — Mid-Cycle Crush / Protein Margins (32%, $59). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns. Drivers — implied_target: 58.96; probability: 0.32.
- Upcycle — Tight Margins (20%, $94). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 94.04; probability: 0.2.
- Spike — Supply Dislocation (8%, $118). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins. Drivers — implied_target: 117.62; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $52 | -10% |
| Peer P/E re-rate | multiple | $70 | +23% |
| Peer EV/Revenue re-rate | multiple | $317 | +454% |
| Scenario PWEV | multiple | $58 | +2% |
| DCF (5-year + terminal) | cash flow + terminal × | $29 | -49% |
| Triangulated (weighted) | — | $47 | -19% |
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $52 + scenario PWEV $58, ≈ spot); the weighted blend $47 (-19%) sits below it because the cash-flow DCF ($29) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $52 and 44% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (68% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.0%, 11x terminal FCF multiple → $29. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 15.725x) implies $70. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Agricultural Products & Protein | $55.7B | 100% | 2% | 3% | 13x | 6% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | ag-processing crush margins / protein cycle + commodity & feed costs |
| net_debt_or_cash_b | -7.58 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.06 |
| div_yield | 0.0349 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | crush / protein margin reset |
| upside | tight crush / protein margins |
Industry Context — Consumer Staples — Ag
This name sits in the Consumer Staples — Ag as a ag_products. ag-processing crush margins / protein cycle + commodity & feed costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: ADM (ag_products) · BG (ag_products) · TSN (ag_products)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Crush / Protein Margin Reset | 40% | 40% | |
| Mid-Cycle — Normalised Margins | 32% | 32% | |
| Tight-Margin Upcycle | 28% | 28% |
On the cluster's key downside — Crush / Protein Margin Reset () — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $57B | $2B | $3B | $3B | $2B | $1B |
| FY+2 | $58B | $2B | $3B | $3B | $2B | $1B |
| FY+3 | $59B | $2B | $4B | $3B | $2B | $1B |
| FY+4 | $59B | $2B | $4B | $3B | $2B | $1B |
| FY+5 | $60B | $2B | $4B | $3B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 11x | $12B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.0% · Σ PV(FCF) $6B + PV(terminal) $12B = EV $18B; + net cash → equity $10B ÷ diluted shares 0.35B = $29/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $44/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 1% vs WACC 9% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| MDLZ | 2.51x | 20.2x | 2% | 9% |
| HSY | 3.389x | 21.32x | 2% | 21% |
| KHC | 1.77x | 11.25x | 2% | 21% |
| GIS | 1.728x | 10.85x | 2% | 19% |
| Median | 2.1399999999999997x | 15.725x | — | — |
Peer-median fwd P/E → $70; EV/Rev → $317.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $29 | 41% | $12 |
| Scenario PWEV | $58 | 29% | $17 |
| Monte Carlo median | $52 | 18% | $9 |
| Peer P/E | $70 | 12% | $8 |
| Triangulated | — | 100% | $47 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 7.7x | 9.3x | 11.0x | 12.6x | 14.3x |
|---|---|---|---|---|---|
| 7% | $22 | $28 | $33 | $39 | $44 |
| 8% | $21 | $26 | $31 | $36 | $42 |
| 9% | $19 | $24 | $29 | $34 | $39 |
| 10% | $18 | $22 | $27 | $32 | $37 |
| 11% | $16 | $21 | $25 | $30 | $34 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $-9 | $10 | $29 | $48 | $67 |
| -1.5pp | $-12 | $9 | $29 | $49 | $70 |
| +0.0pp | $-14 | $7 | $29 | $51 | $73 |
| +1.5pp | $-17 | $6 | $29 | $52 | $75 |
| +3.0pp | $-20 | $5 | $29 | $54 | $78 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $-14 | $73 | $87 |
| Terminal × ±15% | $24 | $34 | $10 |
| WACC ±1pp | $27 | $31 | $4 |
| Revenue CAGR ±3pp | $29 | $29 | $0 |
| FCF conversion ±10% | $29 | $29 | $0 |
Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 13x)
| Multiple | 9.1x | 11.0x | 13.0x | 14.9x | 16.9x |
|---|---|---|---|---|---|
| SoP/share | $1,418 | $1,719 | $2,036 | $2,336 | $2,653 |
Load-Bearing Assumptions
DCF: WACC 9%, terminal multiple 11×, FY+5 revenue $60B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
A miss on Gross Margin drops the case toward the structural target $20.
Fact / Inference / Speculation
- FACT: Spot $57; 52-week range $49–$69; engine rating HOLD; base-case target $58 (+2%).
- INFERENCE: Triangulated FV $47 (-19%). Gross Margin explains 68% of Monte Carlo outcome variance — the single variable that decides which side is right.
- SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 68% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $47 (-19% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (68% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).